Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy

[1]  C. Vasilescu,et al.  Genetic Basis of Severe Childhood-Onset Cardiomyopathies. , 2018, Journal of the American College of Cardiology.

[2]  T. Heliö,et al.  Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure , 2018, PloS one.

[3]  J. Rosenfeld,et al.  Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise. , 2018, Heart rhythm.

[4]  Cristina Has,et al.  Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .

[5]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[6]  Astrid Gall,et al.  Ensembl 2018 , 2017, Nucleic Acids Res..

[7]  J. Rosenfeld,et al.  Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals , 2017, Circulation. Arrhythmia and electrophysiology.

[8]  R. Pautler,et al.  Novel Junctophilin-2 Mutation A405S Is Associated With Basal Septal Hypertrophy and Diastolic Dysfunction , 2017, JACC. Basic to translational science.

[9]  S. Cook,et al.  Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes , 2017, European heart journal.

[10]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[11]  Daniel Rueckert,et al.  Titin truncating variants affect heart function in disease cohorts and the general population , 2016, Nature Genetics.

[12]  M. Sabater-Molina,et al.  Mutation in JPH2 cause dilated cardiomyopathy , 2016, Clinical genetics.

[13]  Anason S. Halees,et al.  Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery , 2016, Nature Genetics.

[14]  Raymond Dalgleish,et al.  HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.

[15]  D. MacArthur,et al.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples , 2016, Genetics in Medicine.

[16]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[17]  Michael Brudno,et al.  PhenomeCentral: A Portal for Phenotypic and Genotypic Matchmaking of Patients with Rare Genetic Diseases , 2015, Human mutation.

[18]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[19]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[20]  A. StAteMent.  ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing , 2014, Genetics in Medicine.

[21]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[22]  X. Wehrens,et al.  Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases. , 2014, Cardiovascular research.

[23]  X. Wehrens,et al.  The junctophilin family of proteins: from bench to bedside. , 2014, Trends in molecular medicine.

[24]  Xiang-Dong Fu,et al.  CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration , 2014, Cell.

[25]  Sivakumar Gowrisankar,et al.  The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing , 2014, Genetics in Medicine.

[26]  M. Ackerman,et al.  Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. , 2013, Journal of the American College of Cardiology.

[27]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[28]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[29]  W. Gao,et al.  Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure. , 2013, Cardiovascular research.

[30]  Michael J Ackerman,et al.  Phylogenetic and Physicochemical Analyses Enhance the Classification of Rare Nonsynonymous Single Nucleotide Variants in Type 1 and 2 Long-QT Syndrome , 2012, Circulation. Cardiovascular genetics.

[31]  Michael J Ackerman,et al.  Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in Mice , 2011, Circulation.

[32]  M. Ackerman,et al.  Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling , 2011, Circulation: Heart Failure.

[33]  Sheng Wei,et al.  T-Tubule Remodeling During Transition From Hypertrophy to Heart Failure , 2010, Circulation research.

[34]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[35]  S. Ommen,et al.  Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. , 2007, Journal of molecular and cellular cardiology.

[36]  Yinhan Liu,et al.  Intermolecular Failure of L-type Ca2+ Channel and Ryanodine Receptor Signaling in Hypertrophy , 2007, PLoS biology.

[37]  Hanan Hamamy,et al.  Genetic disorders in the Arab world , 2006, BMJ : British Medical Journal.

[38]  R. Hershberger,et al.  Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[39]  Y. Ishikawa,et al.  Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. , 2004, Biochemical and biophysical research communications.

[40]  D. Bers.  Cardiac excitation–contraction coupling , 2002, Nature.

[41]  M. Iino,et al.  Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.

[42]  V. Sheffield,et al.  Use of isolated inbred human populations for identification of disease genes. , 1998, Trends in genetics : TIG.

[43]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[44]  C W Balke,et al.  Local calcium transients triggered by single L-type calcium channel currents in cardiac cells. , 1995, Science.

[45]  K. Sullivan,et al.  OpenEpi: Open Source Epidemiologic Statistics for Public Health. Version 2.3.1. , 2013 .

[46]  L. Trümper.  From bench to bedside , 2005, Medizinische Klinik.

[47]  P. Freedson,et al.  Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .